VCR ventracor limited


  1. 423 Posts.
    CMS - A National Coverage Decision for Destination Therapy looks likely now too as all discussions have been very positive.

    The market is big enough for many device makers and all of them are working closely with CMS to better align the DRG payment level with the actual costs of VAD use over time.

    This will increase patient access to Destination Therapy, and US hospitals will be in a far better position to begin making this truly life saving procedure available to their Medicare patients.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.